Cordycepin Reverses Cisplatin Resistance in Non-Small Cell Lung Cancer by Activating AMPK and Inhibiting the AKT Signaling Pathway
Xiaozhong Liao(Sun Yat-sen University), Lizhu Lin(First Affiliated Hospital of Guangzhou University of Chinese Medicine)
Cited by 0
Related Papers
Tanshinone IIA combined with cisplatin synergistically inhibits non‐small‐cell lung cancer in vitro and in vivo via down‐regulating the phosphatidylinositol 3‐kinase/Akt signalling pathway
|Phytotherapy Research|2019|64
Matrine combined with cisplatin synergistically inhibited urothelial bladder cancer cells via down-regulating VEGF/PI3K/Akt signaling pathway
|Cancer Cell International|2017|62
RETRACTED ARTICLE: Tiliroside as a CAXII inhibitor suppresses liver cancer development and modulates E2Fs/Caspase-3 axis
|Scientific Reports|2021|42
RETRACTED ARTICLE: Weipiling ameliorates gastric precancerous lesions in Atp4a−/− mice
|BMC Complementary and Alternative Medicine|2019|14